We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+15.58%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.42B
AUM Growth
+$102M
Cap. Flow
-$464M
Cap. Flow %
-13.58%
Top 10 Hldgs %
31.6%
Holding
114
New
35
Increased
21
Reduced
22
Closed
30

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$96M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$87.8M
3
AAPL icon
Apple
AAPL
+$79.1M
4
BIIB icon
Biogen
BIIB
+$75.7M
5
NOW icon
ServiceNow
NOW
+$63M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$112M
2
AMAT icon
Applied Materials
AMAT
+$90.5M
3
ABBV icon
AbbVie
ABBV
+$61.7M
4
ALDR
Alder Biopharmaceuticals
ALDR
+$57.6M
5
MSFT icon
Microsoft
MSFT
+$52.5M

Sector Composition

Rank Sector Weight
1 Healthcare 36.89%
2 Technology 12.36%
3 Communication Services 7.79%
4 Consumer Discretionary 7.19%
5 Energy 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
1
Biogen
BIIB
$29.5B
$185M 5.41%
590,851
+255,561
+76% +$75.7M
JAZZ icon
2
Jazz Pharmaceuticals
JAZZ
$15.3B
$141M 4.13%
1,161,302
+651,321
+128% +$87.8M
META icon
3
Meta Platforms (Facebook)
META
$1.63T
$114M 3.35%
891,589
+86,410
+11% +$10.7M
EW icon
4
Edwards Lifesciences
EW
$48.9B
$109M 3.18%
2,703,789
-601,314
-18% -$22.6M
UNP icon
5
Union Pacific
UNP
$176B
$100M 2.93%
+1,026,981
New +$96M
AAPL icon
6
Apple
AAPL
$4.81T
$99.2M 2.9%
3,509,392
+2,986,752
+571% +$79.1M
WBA
7
DELISTED
Walgreens Boots Alliance
WBA
$87.6M 2.56%
1,086,425
+254,238
+31% +$20.7M
DISH
8
DELISTED
DISH Network Corp.
DISH
$84.8M 2.48%
1,548,637
+349,906
+29% +$18.1M
PANW icon
9
Palo Alto Networks
PANW
$279B
$80.1M 2.34%
3,015,816
+1,088,352
+56% +$24.8M
AERI
10
DELISTED
Aerie Pharmaceuticals
AERI
$74.2M 2.17%
1,966,417
-375,223
-16% -$8.27M
BAX icon
11
Baxter International
BAX
$11.5B
$70M 2.05%
1,469,562
+113,019
+8% +$5.33M
NOW icon
12
ServiceNow
NOW
$105B
$67.7M 1.98%
+4,274,095
New +$63M
BMRN icon
13
BioMarin Pharmaceuticals
BMRN
$11.4B
$66.9M 1.96%
722,738
+151,634
+27% +$14.3M
MDCO
14
DELISTED
Medicines Co
MDCO
$66M 1.93%
1,748,198
-870,556
-33% -$32.8M
ALDR
15
DELISTED
Alder Biopharmaceuticals
ALDR
$65.8M 1.93%
2,007,664
-1,891,545
-49% -$57.6M
V icon
16
Visa
V
$677B
$65.5M 1.92%
792,535
+556,663
+236% +$44.6M
PXD
17
DELISTED
Pioneer Natural Resource Co.
PXD
$64.9M 1.9%
+349,564
New +$59.5M
BMY icon
18
PUT
Bristol-Myers Squibb
BMY
$124B
$60.6M 1.78%
+1,124,700
New +$72.2M
HRTX icon
19
Heron Therapeutics
HRTX
$90.3M
$58.4M 1.71%
3,390,252
+39,148
+1% +$726K
RRC icon
20
Range Resources
RRC
$8.89B
$54.7M 1.6%
+1,411,978
New +$57.1M
CME icon
21
CME Group
CME
$85.8B
$53.9M 1.58%
+515,625
New +$53.8M
HD icon
22
Home Depot
HD
$331B
$50.8M 1.49%
+394,779
New +$52.6M
AMZN icon
23
Amazon
AMZN
$2.66T
$50.2M 1.47%
1,199,960
-592,520
-33% -$22.7M
ZAYO
24
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$49.3M 1.44%
+1,660,866
New +$48M
VIPS icon
25
Vipshop
VIPS
$7.01B
$48.2M 1.41%
3,283,961
+1,823,212
+125% +$25.6M
1
2 3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
AWP
Abacus Wealth Partners Santa Monica, California $1.1B AUM 14.74% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

PFM Health Sciences's Q3 2016 Portfolio in Review

As of Q3 2016, PFM Health Sciences held 114 positions worth $3.42B, up 3.1% from $3.31B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

PFM Health Sciences withdrew a net $464M in Q3 2016, closing 30 positions and reducing 22 holdings. Its most notable exit was Aetna Inc, an estimated $112M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 39% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Union Pacific worth $100M.

  • PFM Health Sciences's largest Q3 2016 buy was Union Pacific: 1,026,981 shares worth $100M.
  • PFM Health Sciences added most to Jazz Pharmaceuticals in Q3 2016, an estimated $87.8M increase.
  • PFM Health Sciences's biggest Q3 2016 reduction was AbbVie, cutting an estimated $61.7M.
  • PFM Health Sciences fully exited Aetna Inc in Q3 2016, selling an estimated $112M.
  • PFM Health Sciences's ten largest holdings make up 32% of its $3.42B portfolio in Q3 2016.
  • PFM Health Sciences opened 35 new positions and closed 30 in Q3 2016.
  • PFM Health Sciences's portfolio value rose 3.1% quarter-over-quarter to $3.42B.

Based on PFM Health Sciences's 13F filing for Q3 2016, filed 14 Nov 2016.